Most US outpatients not engaged with healthcare, study finds

The majority of outpatients in the US do not feel engaged with their own healthcare, a report by Gensler has found

The majority of outpatients in the US do not feel highly engaged in their own healthcare, a  new study has found. 

The research, conducted by architectural firm Gensler, found that 34% of an outpatient's positive feelings during their visit can be explained by their impressions of the exterior of the facilities they are visiting (15%) and the quality of the exam room (19%).

Gensler conducted the survey among 3,500 people who made recent outpatient visits to a healthcare setting - all during the COVID-19 pandemic. 

While 73% of survey respondents said they felt comfortable during their most recent visit, only 16% said they felt highly engaged in their healthcare. Other findings include: 

  • 50% of respondents rated the quality of their interaction with the clinician positively 
  • 27% have low trust in the future of healthcare
  • 47% of respondents who had a virtual consultation said it was as good as an in-person visit

Gensler's report makes several suggestions to encourage more engagement between patients and their healthcare experience, including:

  • Configuring monitors and screens improves the outpatient’s access to health information and encourages shared decision
  • Handheld digital technologies used to actively facilitate consultations with the physician helped improve the consumers' resilience and coping
  • Creating a clear delineation between exam and consult areas gives the patient a stronger sense of control over their experience and interactions with the physician

To read the full report visit: Gensler - Outpatient Healthcare Experience Index

Share

Featured Articles

McKinsey Health Institute: Focus on Healthcare Insights Body

McKinsey Health Institute generates healthcare insights that McKinsey's consulting teams can draw upon for the benefit of its customers

AstraZeneca & Celonis Map out Digital Transformation

AstraZeneca's Raaj Joshi discusses sustainable innovation in pharmaceutical manufacturing & the company's digital transformation, undertaken with Celonis

Google DeepMind's AlphaFold 3 'is Drug Discovery Boost'

Google DeepMind's AlphaFold 3 is an AI model that can predict the structures and interactions of molecules and will help scientists unlock new medicines

UnitedHealth CEO Admits Hack hit Third of US Citizens' Data

Digital Healthcare

Why Sanofi Leads the way on Healthcare Sustainability

Sustainability

Philips Q1 Results hit by $1.1bn Respironics Settlement

Medical Devices & Pharma